Processing of HEBP1 by cathepsin D gives rise to F2L, the agonist of formyl peptide receptor 3

Journal of Immunology

Volumn 187, Issue 3, 2011, Pages 1475-1485

  Devosse, Thalie ^a   Dutoit, Raphaël ^b   Migeotte, Isabelle ^a   De Nadai, Patricia ^a   Imbault, Virginie ^a   Communi, David ^a   Salmon, Isabelle ^a   Parmentier, Marc ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b Institut de Recherches Microbiologiques J M Wiame   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; BINDING PROTEIN; CATHEPSIN D; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR 3; GLYCINE; HEME BINDING PROTEIN 1; PEPTIDE DERIVATIVE; PEPTIDE F2L; SERINE; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEIN STRUCTURE;

EID: 80051637144     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003545     Document Type: Article

References (53)

1. Lundberg, A. M., and G. K. Hansson. 2010. Innate immune signals in atherosclerosis. Clin. Immunol. 134: 5-24.
2. Libby, P. 2008. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am. J. Med. 121(10, Suppl 1): S21-S31.
3. Mantovani, A., P. Allavena, A. Sica, and F. Balkwill. 2008. Cancer-related inflammation. Nature 454: 436-444.
4. Serbina, N. V., T. Jia, T. M. Hohl, and E. G. Pamer. 2008. Monocyte-mediated defense against microbial pathogens. Annu. Rev. Immunol. 26: 421-452. (Pubitemid 351600381)
5. Zlotnik, A. 2006. Chemokines and cancer. Int. J. Cancer 119: 2026-2029. (Pubitemid 44423657)
6. Rabiet, M. J., E. Huet, and F. Boulay. 2007. The N-formyl peptide receptors and the anaphylatoxin C5a receptors: an overview. Biochimie 89: 1089-1106. (Pubitemid 47260646)
7. Marasco, W. A., S. H. Phan, H. Krutzsch, H. J. Showell, D. E. Feltner, R. Nairn, E. L. Becker, and P. A. Ward. 1984. Purification and identification of formylmethionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J. Biol. Chem. 259: 5430-5439. (Pubitemid 14144994)
8. Schiffmann, E., H. V. Showell, B. A. Corcoran, P. A. Ward, E. Smith, and E. L. Becker. 1975. The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli. J. Immunol. 114: 1831-1837.
9. Schiffmann, E., B. A. Corcoran, and S. M. Wahl. 1975. N-formylmethionyl peptides as chemoattractants for leucocytes. Proc. Natl. Acad. Sci. USA 72: 1059-1062.
10. Showell, H. J., R. J. Freer, S. H. Zigmond, E. Schiffmann, S. Aswanikumar, B. Corcoran, and E. L. Becker. 1976. The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils. J. Exp. Med. 143: 1154-1169.
11. Boulay, F., M. Tardif, L. Brouchon, and P. Vignais. 1990. The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. Biochemistry 29: 11123-11133.
12. Boulay, F., M. Tardif, L. Brouchon, and P. Vignais. 1990. Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA. Biochem. Biophys. Res. Commun. 168: 1103-1109. (Pubitemid 20175994)
13. Bao, L., N. P. Gerard, R. L. Eddy, Jr., T. B. Shows, and C. Gerard. 1992. Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19. Genomics 13: 437-440.
14. Murphy, P. M., T. Ozçelik, R. T. Kenney, H. L. Tiffany, D. McDermott, and U. Francke. 1992. A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family. J. Biol. Chem. 267: 7637-7643.
15. Ye, R. D., S. L. Cavanagh, O. Quehenberger, E. R. Prossnitz, and C. G. Cochrane. 1992. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. Biochem. Biophys. Res. Commun. 184: 582-589.
16. Migeotte, I., D. Communi, and M. Parmentier. 2006. Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev. 17: 501-519. (Pubitemid 44793122)
17. Durstin, M., J. L. Gao, H. L. Tiffany, D. McDermott, and P. M. Murphy. 1994. Differential expression of members of the N-formylpeptide receptor gene cluster in human phagocytes. Biochem. Biophys. Res. Commun. 201: 174-179. (Pubitemid 24213710)
18. Devosse, T., A. Guillabert, N. D'Haene, A. Berton, P. De Nadai, S. Noel, M. Brait, J. D. Franssen, S. Sozzani, I. Salmon, and M. Parmentier. 2009. Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophils. J. Immunol. 182: 4974-4984.
19. Harada, M., Y. Habata, M. Hosoya, K. Nishi, R. Fujii, M. Kobayashi, and S. Hinuma. 2004. N-Formylated humanin activates both formyl peptide receptor-like 1 and 2. Biochem. Biophys. Res. Commun. 324: 255-261. (Pubitemid 39311487)
20. Ying, G., P. Iribarren, Y. Zhou, W. Gong, N. Zhang, Z. X. Yu, Y. Le, Y. Cui, and J. M. Wang. 2004. Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor. J. Immunol. 172: 7078-7085. (Pubitemid 38669150)
21. Migeotte, I., E. Riboldi, J. D. Franssen, F. Grégoire, C. Loison, V. Wittamer, M. Detheux, P. Robberecht, S. Costagliola, G. Vassart, et al. 2005. Identification and characterization of an endogenous chemotactic ligand specific for FPRL2. J. Exp. Med. 201: 83-93. (Pubitemid 40130086)
22. Taketani, S., Y. Adachi, H. Kohno, S. Ikehara, R. Tokunaga, and T. Ishii. 1998. Molecular characterization of a newly identified heme-binding protein induced during differentiation of urine erythroleukemia cells. J. Biol. Chem. 273: 31388-31394. (Pubitemid 28533157)
23. Zylka, M. J., and S. M. Reppert. 1999. Discovery of a putative heme-binding protein family (SOUL/HBP) by two-tissue suppression subtractive hybridization and database searches. Brain Res. Mol. Brain Res. 74: 175-181. (Pubitemid 30038191)
24. Dias, J. S., A. L. Macedo, G. C. Ferreira, F. C. Peterson, B. F. Volkman, and B. J. Goodfellow. 2006. The first structure from the SOUL/HBP family of heme-binding proteins, murine P22HBP. J. Biol. Chem. 281: 31553-31561. (Pubitemid 46041421)
25. Gell, D. A., B. J. Westman, D. Gorman, C. K. Liew, J. J. Welch, M. J. Weiss, and J. P. Mackay. 2006. A novel haem-binding interface in the 22 kDa haem-binding protein p22HBP. J. Mol. Biol. 362: 287-297. (Pubitemid 44278849)
26. Dutoit, R., E. Dubois, and E. Jacobs. 2010. Selection systems based on dominant-negative transcription factors for precise genetic engineering. Nucleic Acids Res. 38: e183.
27. Ito, H., Y. Fukuda, K. Murata, and A. Kimura. 1983. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153: 163-168. (Pubitemid 13119852)
28. Button, D., and M. Brownstein. 1993. Aequorin-expressing mammalian cell lines used to report Ca2+ mobilization. Cell Calcium 14: 663-671. (Pubitemid 23289450)
29. Le Poul, E., S. Hisada, Y. Mizuguchi, V. J. Dupriez, E. Burgeon, and M. Detheux. 2002. Adaptation of aequorin functional assay to high throughput screening. J. Biomol. Screen. 7: 57-65. (Pubitemid 34208863)
30. Mortz, E., T. N. Krogh, H. Vorum, and A. Görg. 2001. Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics 1: 1359-1363. (Pubitemid 33587891)
31. Boyden, S. 1962. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J. Exp. Med. 115: 453-466.
32. Polevoda, B., and F. Sherman. 2000. Nalpha -terminal acetylation of eukaryotic proteins. J. Biol. Chem. 275: 36479-36482. (Pubitemid 32002039)
33. Polevoda, B., and F. Sherman. 2003. N-terminal acetyltransferases and sequence requirements for N-terminal acetylation of eukaryotic proteins. J. Mol. Biol. 325: 595-622. (Pubitemid 36268685)
34. Polevoda, B., and F. Sherman. 2002. The diversity of acetylated proteins. Genome Biol. 3: reviews0006.
35. Gao, J. L., A. Guillabert, J. Hu, Y. Le, E. Urizar, E. Seligman, K. J. Fang, X. Yuan, V. Imbault, D. Communi, et al. 2007. F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affinity N-formylpeptide receptor. J. Immunol. 178: 1450-1456. (Pubitemid 46154616)
36. Dias, J. S., A. L. Macedo, G. C. Ferreira, N. Jeanty, S. Taketani, B. J. Goodfellow, F. C. Peterson, and B. F. Volkman. 2005. 1H, 15N and 13C resonance assignments of the heme-binding protein murine p22HBP. J. Biomol. NMR 32: 338. (Pubitemid 41511521)
37. Tapper, H., and R. Sundler. 1990. Role of lysosomal and cytosolic pH in the regulation of macrophage lysosomal enzyme secretion. Biochem. J. 272: 407-414.
38. Benes, P., V. Vetvicka, and M. Fusek. 2008. Cathepsin D - many functions of one aspartic protease. Crit. Rev. Oncol. Hematol. 68: 12-28.
39. Conus, S., R. Perozzo, T. Reinheckel, C. Peters, L. Scapozza, S. Yousefi, and H. U. Simon. 2008. Caspase-8 is activated by cathepsin D initiating neutrophil apoptosis during the resolution of inflammation. J. Exp. Med. 205: 685-698. (Pubitemid 351439313)
40. Minarowska, A., M. Gacko, A. Karwowska, and L. Minarowski. 2008. Human cathepsin D. Folia Histochem. Cytobiol. 46: 23-38.
41. Zavasnik-Bergant, T., and B. Turk. 2007. Cysteine proteases: destruction ability versus immunomodulation capacity in immune cells. Biol. Chem. 388: 1141-1149. (Pubitemid 350059624)
42. Fruitier, I., I. Garreau, and J. M. Piot. 1998. Cathepsin D is a good candidate for the specific release of a stable hemorphin from hemoglobin in vivo: VV-hemorphin-7. Biochem. Biophys. Res. Commun. 246: 719-724. (Pubitemid 28420924)
43. Cohen, M., I. Fruitier-Arnaudin, and J. M. Piot. 2004. Hemorphins: substrates and/or inhibitors of dipeptidyl peptidase IV. Hemorphins N-terminus sequence influence on the interaction between hemorphins and DPPIV. Biochimie 86: 31-37. (Pubitemid 38264276)
44. Lantz, I., E. L. Glämsta, L. Talbäck, and F. Nyberg. 1991. Hemorphins derived from hemoglobin have an inhibitory action on angiotensin converting enzyme activity. FEBS Lett. 287: 39-41.
45. Dagouassat, N., I. Garreau, F. Sannier, Q. Zhao, and J. M. Piot. 1996. Generation of VV-hemorphin-7 from globin by peritoneal macrophages. FEBS Lett. 382: 37-42. (Pubitemid 26092940)
46. Deiss, L. P., H. Galinka, H. Berissi, O. Cohen, and A. Kimchi. 1996. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J. 15: 3861-3870. (Pubitemid 26289796)
47. Conus, S., and H. U. Simon. 2008. Cathepsins: key modulators of cell death and inflammatory responses. Biochem. Pharmacol. 76: 1374-1382.
48. Nickel, W., and C. Rabouille. 2009. Mechanisms of regulated unconventional protein secretion. Nat. Rev. Mol. Cell Biol. 10: 148-155.
49. Lkhider, M., R. Castino, E. Bouguyon, C. Isidoro, and M. Ollivier-Bousquet. 2004. Cathepsin D released by lactating rat mammary epithelial cells is involved in prolactin cleavage under physiological conditions. J. Cell Sci. 117: 5155-5164. (Pubitemid 39517530)
50. Baechle, D., T. Flad, A. Cansier, H. Steffen, B. Schittek, J. Tolson, T. Herrmann, H. Dihazi, A. Beck, G. A. Mueller, et al. 2006. Cathepsin D is present in human eccrine sweat and involved in the postsecretory processing of the antimicrobial peptide DCD-1L. J. Biol. Chem. 281: 5406-5415. (Pubitemid 43847635)
51. Fusek, M., and V. Vetvicka. 2005. Dual role of cathepsin D: ligand and protease. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 149: 43-50.
52. Liaudet-Coopman, E., M. Beaujouin, D. Derocq, M. Garcia, M. Glondu-Lassis, V. Laurent-Matha, C. Prébois, H. Rochefort, and F. Vignon. 2006. Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis. Cancer Lett. 237: 167-179. (Pubitemid 43777078)
53. Hakala, J. K., R. Oksjoki, P. Laine, H. Du, G. A. Grabowski, P. T. Kovanen, and M. O. Pentikäinen. 2003. Lysosomal enzymes are released from cultured human macrophages, hydrolyze LDL in vitro, and are present extracellularly in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 23: 1430-1436. (Pubitemid 37006376)